These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27552711)

  • 21. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR; Kraemer DF; Winter C; Neuwelt EA
    J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis.
    Al-Malky G; Dawson SJ; Sirimanna T; Bagkeris E; Suri R
    J Cyst Fibros; 2015 Mar; 14(2):248-54. PubMed ID: 25127922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease.
    Sakashita T; Shibata T; Yamane H; Hikawa C
    Acta Otolaryngol Suppl; 2004 Oct; (554):26-9. PubMed ID: 15513506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distortion product otoacoustic emissions and tympanometric measurements in an adult population-based study.
    Uchida Y; Ando F; Nakata S; Ueda H; Nakashima T; Niino N; Shimokata H
    Auris Nasus Larynx; 2006 Dec; 33(4):397-401. PubMed ID: 16753276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal exposure to Aroclor 1254 impairs distortion product otoacoustic emissions (DPOAEs) in rats.
    Lasky RE; Widholm JJ; Crofton KM; Schantz SL
    Toxicol Sci; 2002 Aug; 68(2):458-64. PubMed ID: 12151642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cisplatin chemotherapy on the inner ear function and serum prestin concentration.
    Jalali MM; Saedi HS; Saadat F
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):2783-2789. PubMed ID: 34213608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Applying distortion product otoacoustic emission in testing human sensory hearing loss].
    Chen X; Zheng H; Zheng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):382-4. PubMed ID: 15181843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ototoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions.
    Md Daud MK; Mohamadl H; Haron A; Rahman NA
    B-ENT; 2014; 10(1):53-8. PubMed ID: 24765829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Otoacoustic emissions and recruitment].
    Konopka W; Olszewski J
    Otolaryngol Pol; 2005; 59(5):731-6. PubMed ID: 16471192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of distortion-product otoacoustic emissions in well-drilling workers].
    Zhang QR; Lei ZX; Shi JH; Wang KX; Huang J; Wu HF; Xiong X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Feb; 14(2):78-80. PubMed ID: 12541483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the effectiveness of otoacoustic emissions for evaluating hearing status after newborn screening.
    Janssen T
    Otol Neurotol; 2013 Aug; 34(6):1058-63. PubMed ID: 23628790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hearing evaluation in children during chemotherapy].
    Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
    Pol Merkur Lekarski; 2005 Sep; 19(111):340-2. PubMed ID: 16358863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Objective audiometry with DPOAEs : New findings for generation mechanisms and clinical applications. German version].
    Zelle D; Dalhoff E; Gummer AW
    HNO; 2016 Nov; 64(11):822-830. PubMed ID: 27761597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensorineural hearing loss in β-thalassemia patients treated with iron chelation.
    Osma U; Kurtoglu E; Eyigor H; Yilmaz MD; Aygener N
    Ear Nose Throat J; 2015 Dec; 94(12):481-5. PubMed ID: 26670754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency distortion product otoacoustic emissions in children with and without middle ear dysfunction.
    Kei J; Brazel B; Crebbin K; Richards A; Willeston N
    Int J Pediatr Otorhinolaryngol; 2007 Jan; 71(1):125-33. PubMed ID: 17126413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related shifts in distortion product otoacoustic emissions peak-ratios and amplitude modulation spectra.
    Lai J; Bartlett EL
    Hear Res; 2015 Sep; 327():186-98. PubMed ID: 26232530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental exposure to PCBs, MeHg, or both: long-term effects on auditory function.
    Powers BE; Poon E; Sable HJ; Schantz SL
    Environ Health Perspect; 2009 Jul; 117(7):1101-7. PubMed ID: 19654920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating cochlear function and the effects of noise exposure in the B6.CAST+Ahl mouse with distortion product otoacoustic emissions.
    Vázquez AE; Jimenez AM; Martin GK; Luebke AE; Lonsbury-Martin BL
    Hear Res; 2004 Aug; 194(1-2):87-96. PubMed ID: 15276680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical investigation on spontaneous otoacoustic emission (SOAE) in 447 ears.
    Kuroda T
    Auris Nasus Larynx; 2007 Mar; 34(1):29-38. PubMed ID: 17116381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.